News
AXGN
55.75
-1.06%
-0.60
Axogen Is Maintained at Outperform by Leerink Partners
Dow Jones · 1d ago
Axogen Price Target Raised to $65.00/Share From $56.00 by Leerink Partners
Dow Jones · 1d ago
Leerink Partners Maintains Outperform on Axogen, Raises Price Target to $65
Benzinga · 1d ago
MedTech poised to outperform in 2027, Leerink says as Abbott upgraded
Seeking Alpha · 1d ago
AxoGen price target raised to $65 from $56 at Leerink
TipRanks · 1d ago
Weekly Report: what happened at AXGN last week (1109-1113)?
Weekly Report · 4d ago
Earnings Upgrades Could Be A Big Deal For Axogen Stock (AXGN)
Simply Wall St · 6d ago
AxoGen Earnings Call Highlights Growth and BioCircuit Momentum
TipRanks · 11/13 00:22
AxoGen (AXGN) is a Great Momentum Stock: Should You Buy?
NASDAQ · 11/12 16:00
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and AxoGen (AXGN)
TipRanks · 11/12 12:20
Axogen, Inc. Announces Decision to Move Forward with Prostate Market Launch and Highlights $754m TAM
NASDAQ · 11/09 20:28
AxoGen Highlights Prostate Nerve Reconstruction Opportunity and Clinical Results
TipRanks · 11/09 14:19
Weekly Report: what happened at AXGN last week (1102-1106)?
Weekly Report · 11/09 09:18
Axogen (AXGN) Raised Its 2026 Outlook, Is The Upside Already Priced In?
Simply Wall St · 11/09 06:19
Should Raised Revenue Guidance Require Action From Axogen (AXGN) Investors?
Simply Wall St · 11/07 09:35
Axogen Consensus Price Target Raised 10.66% to $60.27
NASDAQ · 11/02 16:39
Weekly Report: what happened at AXGN last week (1026-1030)?
Weekly Report · 11/02 09:18
Learn Why The Bull Case For Axogen (AXGN) Could Change Following Raised Revenue Guidance
Simply Wall St · 10/31 08:31
Axogen: Taking The Friction Out Of Nerve Repair
Seeking Alpha · 10/30 16:25
AxoGen (AXGN) Gets a Buy from Truist Financial
TipRanks · 10/30 02:25
More
Webull provides a variety of real-time AXGN stock news. You can receive the latest news about Axogen Inc through multiple platforms. This information may help you make smarter investment decisions.
About AXGN
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, Avive+ Soft Tissue Matrix, and NerveTape. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel.